about
Evolutionary dynamics of immune-related genes and pathways in disease-vector mosquitoesStructural basis for conserved complement factor-like function in the antimalarial protein TEP1.Bacterial alpha2-macroglobulins: colonization factors acquired by horizontal gene transfer from the metazoan genome?Transgenic Expression of the Anti-parasitic Factor TEP1 in the Malaria Mosquito Anopheles gambiae.Reverse genetics in the mosquito Anopheles gambiae: targeted disruption of the Defensin geneMosquito immune responses against malaria parasites.Mosaic genome architecture of the Anopheles gambiae species complexComplement-like protein TEP1 is a determinant of vectorial capacity in the malaria vector Anopheles gambiae.Mosquito genomics. Highly evolvable malaria vectors: the genomes of 16 Anopheles mosquitoes.Antimalarial responses in Anopheles gambiae: from a complement-like protein to a complement-like pathway.Two mosquito LRR proteins function as complement control factors in the TEP1-mediated killing of Plasmodium.Thioester-containing proteins and insect immunity.Tools for Anopheles gambiae Transgenesis.The Redox Cycler Plasmodione Is a Fast-Acting Antimalarial Lead Compound with Pronounced Activity against Sexual and Early Asexual Blood-Stage Parasites.Phagocytosis in mosquito immune responses.Silencing of Toll pathway components by direct injection of double-stranded RNA into Drosophila adult flies.Dissecting the genetic basis of resistance to malaria parasites in Anopheles gambiae.Immunity-related genes and gene families in Anopheles gambiae.In vivo identification of novel regulators and conserved pathways of phagocytosis in A. gambiae.Silencing of genes and alleles by RNAi in Anopheles gambiae.Boosting NF-kappaB-dependent basal immunity of Anopheles gambiae aborts development of Plasmodium berghei.Malaria Plasmodium agent induces alteration in the head proteome of their Anopheles mosquito host.The solubility and stability of recombinant proteins are increased by their fusion to NusA.[Curing mosquitoes to control malaria?].Author Correction: Arylmethylamino steroids as antiparasitic agentsInvestigating the mode of action of the redox-active antimalarial drug plasmodione using the yeast model
P50
Q24674617-85627A2A-A849-4889-AC67-8EC972B4B36AQ24681538-498B7ADF-5AAD-4FF9-A258-4FB1C8DC282DQ24804769-79F9C535-5F40-4E66-BF13-944F8347B5A5Q30313539-8AF31526-C186-491D-9841-8CFB451B9F3DQ31104825-575CC46B-F180-438C-9E96-741D7D07E9F1Q33196975-2ECC7A13-30B1-4508-9274-42F266DCB70FQ33307553-A2C2D79C-CA0C-41EA-93E0-57D9A42B5D72Q34303767-1E42D81C-C704-4BB0-9226-BFA48B67EFF8Q34456356-F42E87D0-6A16-4B2A-9466-237B04F5BAB2Q34785539-6B7C60D8-84A0-470C-A133-E0D6DF812AEBQ34962505-0CB9D4B2-CB96-4333-B5BA-50D99F5A7395Q35617628-A9AE6DED-982A-4739-9453-5090950A4CB7Q35773999-54205C92-E67F-44AA-A958-DADFE7843E2EQ36051237-9BF9EFDE-C971-45A6-A78B-CB87958A1721Q36938585-B1D86078-B6CE-4D0B-8A2A-23833C556D71Q37371055-5B62C80A-1A23-41E3-8AF9-44BB6ED2D3A7Q42115450-AEE81FD1-AD8C-4EC6-A519-16D0A66DADFFQ44149321-215A8F63-9768-4D2B-9560-BA0C4AA8618FQ44165485-6ED4EFF1-C8DB-40A4-9273-E2C0ACAC76A0Q44165825-64A41A72-E4DE-4C1B-8DBE-73BDE706B628Q44170369-189DECA8-1B68-41F6-A36D-DE74A457CB88Q44172208-1DC64FF7-B006-4FD7-B385-1D47E22FC475Q45035964-93F62751-9EC5-44DB-B506-F03BFAD82B97Q47992582-AF5B9A2D-6168-4927-B44F-16E7D9C3C140Q91722425-3B5691EF-7031-43D4-AA92-C027EE515495Q93015158-D5288E68-0200-4231-B676-AFFD98300812
P50
description
hulumtuese
@sq
onderzoeker
@nl
researcher
@en
հետազոտող
@hy
name
Stephanie Blandin
@ast
Stephanie Blandin
@en
Stephanie Blandin
@es
Stephanie Blandin
@nl
type
label
Stephanie Blandin
@ast
Stephanie Blandin
@en
Stephanie Blandin
@es
Stephanie Blandin
@nl
prefLabel
Stephanie Blandin
@ast
Stephanie Blandin
@en
Stephanie Blandin
@es
Stephanie Blandin
@nl
P214
P1053
I-2786-2016
P106
P21
P214
P31
P496
0000-0003-4566-1200
P735
P7859
viaf-204843427